Gotham Asset Management, LLC

Position in COLL — Collegium Pharmaceutical, Inc

CIK 1510387 NEW YORK, NY

Position in COLL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,767,164

+$928,010 QoQ

Shares Held

76,441

+37.4% QoQ

Ownership

0.235%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#61

of 277 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Gotham Asset Management, LLC holds $248,215,917 across 22 Drug Manufacturers - Specialty & Generic names. COLL ranks #8 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	4,374,683	$69,469,966
2	NBIX	Neurocrine Biosciences Inc	371,568	$62,624,070
3	UTHR	UNITED THERAPEUTICS Corp	79,123	$42,871,215
4	ZTS	Zoetis Inc.	531,415	$38,187,481
5	ELAN	Elanco Animal Health Inc	465,714	$11,461,221
6	PRGO	PERRIGO Co plc	435,648	$4,526,382
7	INDV	Indivior Pharmaceuticals, Inc.	94,850	$3,891,695
8	COLL	Collegium Pharmaceutical, Inc This page	76,441	$2,767,164

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,767,164	76,441	+37.4%	Shares	Sole	2026-08-14
2026-03-31	$1,839,154	55,614	+434.5%	Shares	Sole	2026-05-15
2025-12-31	$481,705	10,404	+27.1%	Shares	Sole	2026-02-17
2025-09-30	$286,393	8,185	-70.8%	Shares	Sole	2025-11-14
2024-12-31	$804,320	28,074	-46.1%	Shares	Sole	2025-02-14
2024-09-30	$2,013,375	52,106	-15.2%	Shares	Sole	2024-11-14
2024-06-30	$1,977,627	61,417	+17.2%	Shares	Sole	2024-08-14
2024-03-31	$2,035,022	52,422	+16.9%	Shares	Sole	2024-05-15
2023-12-31	$1,380,852	44,862	+4.4%	Shares	Sole	2024-02-14
2023-09-30	$960,223	42,963	+32.3%	Shares	Sole	2023-11-14
2023-06-30	$697,866	32,474	+140.9%	Shares	Sole	2023-08-14
2023-03-31	$323,433	13,482	+18.8%	Shares	Sole	2023-05-15
2021-06-30	$268,266	11,348	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.